The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2020 | Latest updates in lymphoma trials
David J. Straus, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the latest clinical trials in lymphoma, including an ongoing study evaluating interim PET scans to tailor treatment in stage III/IV disease in addition to an ongoing study evaluating brentuximab vedotin and nivolumab, also in stage III/IV disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
